Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results
about
Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerationsImpact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic FibrosisBronchodilators in cystic fibrosis: a critical analysis.Long-acting inhaled bronchodilators for cystic fibrosis.
P2860
Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Testing two different doses of ...... ase 2 randomized trial results
@ast
Testing two different doses of ...... ase 2 randomized trial results
@en
Testing two different doses of ...... ase 2 randomized trial results
@nl
type
label
Testing two different doses of ...... ase 2 randomized trial results
@ast
Testing two different doses of ...... ase 2 randomized trial results
@en
Testing two different doses of ...... ase 2 randomized trial results
@nl
prefLabel
Testing two different doses of ...... ase 2 randomized trial results
@ast
Testing two different doses of ...... ase 2 randomized trial results
@en
Testing two different doses of ...... ase 2 randomized trial results
@nl
P2093
P2860
P50
P1433
P1476
Testing two different doses of ...... ase 2 randomized trial results
@en
P2093
David E Geller
Paul Koker
Petra Moroni-Zentgraf
Tiotropium Cystic Fibrosis Study Group
P2860
P304
P356
10.1371/JOURNAL.PONE.0106195
P407
P577
2014-09-04T00:00:00Z